UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 266

Sortiert nach

Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury

Toxicological sciences, 2008-09, Vol.105 (1), p.97-105

2008

Volltextzugriff (PDF)

Identification of Endoglin as a Functional Marker That Defines Long-Term Repopulating Hematopoietic Stem Cells

Proceedings of the National Academy of Sciences - PNAS, 2002-11, Vol.99 (24), p.15468-15473

2002

Volltextzugriff (PDF)

A protein interaction atlas for the nuclear receptors: properties and quality of a hub-based dimerisation network

BMC systems biology, 2007-07, Vol.1 (1), p.34-34, Article 34

2007

Volltextzugriff (PDF)

Involvement ofMDR1 P-glycoprotein in multifactorial resistance to methotrexate

International journal of cancer, 1996-03, Vol.65 (5), p.613-619

1996

Volltextzugriff (PDF)

A network-based approach to quantifying the impact of biologically active substances

Drug discovery today, 2012-05, Vol.17 (9-10), p.413-418

2012

Volltextzugriff (PDF)

A decade of Systems Biology: where are we and where are we going to?

Drug discovery today, 2014-02, Vol.19 (2), p.105-107

2014

Volltextzugriff (PDF)

Multiple effects of acetaminophen and p38 inhibitors: Towards pathway toxicology

FEBS letters, 2008-04, Vol.582 (8), p.1276-1282

2008

Volltextzugriff (PDF)

Applying computational modeling to drug discovery and development

Drug discovery today, 2006-09, Vol.11 (17), p.806-811

2006

Volltextzugriff (PDF)

Systems diagnostics: anticipating the next generation of diagnostic tests based on mechanistic insight into disease

Drug discovery today, 2014-02, Vol.19 (2), p.108-112

2014

Volltextzugriff (PDF)

Verification of systems biology research in the age of collaborative competition

Nature biotechnology, 2011-09, Vol.29 (9), p.811-815

2011

Volltextzugriff (PDF)

Involvement of MDR1 P‐glycoprotein in multifactorial resistance to methotrexate

International journal of cancer, 1996-03, Vol.65 (5), p.613-619

1996

Volltextzugriff (PDF)

Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis

BMC medical genomics, 2015-06, Vol.8 (1), p.26-26, Article 26

2015

Volltextzugriff (PDF)

568 Therapeutic Diagnostic: Identification of Molecular Mechanisms Underlying Ulcerative Colitis in Infliximab Non-Responders at Baseline

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-115-S-115

2012

Volltextzugriff (PDF)

Abstract 703: Verification of a novel approach to identify disease mechanisms in breast cancer patient subsets and application of this approach to indicating and characterizing tamoxifen resistance

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.703-703

2012

Volltextzugriff (PDF)

Early patient stratification and predictive biomarkers in drug discovery and development: a case study of ulcerative colitis anti-TNF therapy

Advances in experimental medicine and biology, 2012, Vol.736, p.645

2012

Volltextzugriff (PDF)

Elevated GM-CSF and IL-1β levels compromise the ability of p38 MAPK inhibitors to modulate TNFα levels in the human monocytic/macrophage U937 cell line

Molecular bioSystems, 2010-01, Vol.6 (10), p.1956

2010

Volltextzugriff (PDF)

Elevated GM-CSF and IL-1β levels compromise the ability of p38 MAPK inhibitors to modulate TNFα levels in the human monocytic/macrophage U937 cell lineElectronic supplementary information (ESI) available: 6 Supplementary Figures, 3 datasets used to generate figures in the manuscript and supplementary methods. See DOI: 10.1039/c002848g

2010-10

Volltextzugriff (PDF)

Company Profile: Selventa, Inc

Personalized medicine, 2012-08, Vol.9 (6), p.579-583

2012

Volltextzugriff (PDF)

P-Glycoprotein Confers Methotrexate Resistance in 3T6 Cells with Deficient Carrier-Mediated Methotrexate Uptake

Proceedings of the National Academy of Sciences - PNAS, 1996-02, Vol.93 (3), p.1238-1242

1996

Volltextzugriff (PDF)

Elevated GM-CSF and IL-1beta levels compromise the ability of p38 MAPK inhibitors to modulate TNFalpha levels in the human monocytic/macrophage U937 cell line

Molecular bioSystems, 2010-10, Vol.6 (10), p.1956-1972

2010

Volltextzugriff (PDF)

Chapter 25 Systems Biology and Kinase Signaling

Annual Reports in Medicinal Chemistry, 2007, Vol.42, p.393,626-400,627

2007

Volltextzugriff (PDF)

Human (MDR1) and Mouse (mdr1,mdr3) P-glycoproteins Can Be Distinguished by Their Respective Drug Resistance Profiles and Sensitivity to Modulators

Biochemistry (Easton), 1995, Vol.34 (1), p.32-39

1995

Volltextzugriff (PDF)

[16] Isolation of altered-function mutants and genetic suppressor elements of multidrug transporter P-glycoprotein by expression selection from retroviral libraries

Methods in Enzymology, 1998, Vol.292, p.225-248

1998

Volltextzugriff (PDF)

Determinants of MDR1 P-glycoprotein substrate specificity

de Graaf, David

1995

Volltextzugriff (PDF)

1 – 25 von 266

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(243)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(266)
Japanisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury

Identification of Endoglin as a Functional Marker That Defines Long-Term Repopulating Hematopoietic Stem Cells

A protein interaction atlas for the nuclear receptors: properties and quality of a hub-based dimerisation network

Involvement ofMDR1 P-glycoprotein in multifactorial resistance to methotrexate

A network-based approach to quantifying the impact of biologically active substances

A decade of Systems Biology: where are we and where are we going to?

Multiple effects of acetaminophen and p38 inhibitors: Towards pathway toxicology

Applying computational modeling to drug discovery and development

Systems diagnostics: anticipating the next generation of diagnostic tests based on mechanistic insight into disease

Verification of systems biology research in the age of collaborative competition

Involvement of MDR1 P‐glycoprotein in multifactorial resistance to methotrexate

Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis

568 Therapeutic Diagnostic: Identification of Molecular Mechanisms Underlying Ulcerative Colitis in Infliximab Non-Responders at Baseline

Abstract 703: Verification of a novel approach to identify disease mechanisms in breast cancer patient subsets and application of this approach to indicating and characterizing tamoxifen resistance

Early patient stratification and predictive biomarkers in drug discovery and development: a case study of ulcerative colitis anti-TNF therapy

Elevated GM-CSF and IL-1β levels compromise the ability of p38 MAPK inhibitors to modulate TNFα levels in the human monocytic/macrophage U937 cell line

Verification of systems biology research in the age of collaborative competition: collaborative competitions in which communities of researchers compete to solve challenges may facilitate more rigorous scrutiny of scientific results

Company Profile: Selventa, Inc

P-Glycoprotein Confers Methotrexate Resistance in 3T6 Cells with Deficient Carrier-Mediated Methotrexate Uptake

Elevated GM-CSF and IL-1beta levels compromise the ability of p38 MAPK inhibitors to modulate TNFalpha levels in the human monocytic/macrophage U937 cell line

Chapter 25 Systems Biology and Kinase Signaling

Human (MDR1) and Mouse (mdr1,mdr3) P-glycoproteins Can Be Distinguished by Their Respective Drug Resistance Profiles and Sensitivity to Modulators

[16] Isolation of altered-function mutants and genetic suppressor elements of multidrug transporter P-glycoprotein by expression selection from retroviral libraries

Determinants of MDR1 P-glycoprotein substrate specificity

Suchergebnisse filtern